or Try an Advanced Search...

    ETF Components for PPH - Market Vectors Pharmaceutical ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    LLY D 1.96 12.02
    NVO B 2.70 9.63
    JNJ F 0.30 6.59
    MRK A -0.05 6.31
    ABBV C 0.98 5.71
    AZN A 1.03 5.52
    NVS B 2.27 4.87
    MCK A 0.89 4.69
    SNY C 1.15 4.57
    HLN B 0.60 4.56
    PFE F 0.23 4.49
    GSK C 1.60 4.48
    BMY F -0.31 4.29
    TAK F 0.15 4.23
    ZTS F 2.76 3.85
    TEVA D 1.01 2.78
    VTRS C 0.98 1.86
    JAZZ F 0.77 1.06
    CTLT D -0.04 0.98
    ELAN D 4.10 0.85
    PRGO B 1.43 0.64
    OGN B 2.89 0.58
    PDCO D 0.23 0.31

    Represented by ETF Holdings

    Keywords: Pharmaceutical Products S&P 500 Pharmaceutical Animal Health Life Sciences Antibiotics Biopharmaceutical Cancer Drugs Medication Pain Biotechnology Depressive Disorder Diabetes Hypertension Infection Infectious Diseases Active Pharmaceutical Ingredients Gastrointestinal Health Products
    Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Biotechnology Medical Distribution Drug Manufacturers - General

    Recent News for Market Vectors Pharmaceutical ETF & its Holdings

    Date Stock Title
    Apr 24 NVO Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
    Apr 24 NVO About 3.6 mln Medicare beneficiaries could be eligible for Wegovy coverage, study shows
    Apr 23 NVS Why Novartis Stock Topped the Market on Tuesday
    Apr 23 LLY TikTok to restrict weight loss drug promotion (updated)
    Apr 23 ABBV Nvidia will soar 21% to $1,000 as its new AI chip slams would-be rivals, Morgan Stanley says. It’s among 10 stocks set to surge
    Apr 23 NVS FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors
    Apr 23 TAK Neurocrine succeeds in mid-stage trial for Takeda-partnered depression drug
    Apr 23 NVS Novartis wins pediatric indication for Lutathera for rare cancer
    Apr 23 NVS Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
    Apr 23 SNY Sanofi reportedly lining up banks for consumer products spinoff
    Apr 23 BMY S&P 500 stocks with biggest estimated EPS declines for Q1
    Apr 23 SNY Sanofi Asks Banks to Pitch for $20 Billion OTC Spinoff
    Apr 23 NVS Top Midday Stories: Shares of GE, Novartis, Danaher and Philip Morris Up Post-Earnings; Pepsi Stock Down Post-Earnings; Apple iPhone China Sales Drop 19%; Trump Poised for Windfall From Media Company Stock
    Apr 23 ZTS Zoetis (ZTS) Fell After Reporting Mixed Fourth Quarter Results
    Apr 23 SNY Sanofi (SNY) Rilzabrutinib Shows Benefit in Blood Disorder Study
    Apr 23 NVS Novartis AG (NVS) Q1 2024 Earnings Call Transcript
    Apr 23 NVS Novartis Stock Jumps After Beating Expectations, Raising Guidance
    Apr 23 NVO TikTok to restrict weight loss drug promotion
    Apr 23 NVS Novartis Ag (NVS) Q1 2024 Earnings Call Transcript
    Apr 23 NVS Novartis raises full-year guidance on Q1 beat, drug sales
    The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Pharmaceutical 25 Index (the "Pharmaceutical Index"). The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
    Exchange Traded Fund ETF Stock Market Index Depositary Receipt
    Back to the Main PPH Page...